Sweden’s fastest-growing private biotech, Anocca, has plans for clinical trials in pancreatic cancer using its VIDAR-1 TCR-T cell therapy. Since its inception, the company has raised €100m+ and has formed partnerships with EmendoBio and Shinobi Therapeutics. The company’s CEO, Reagan Jarvis, discusses the evolution of TCR-T therapy, the impact of AI, and their unique approach to treatments.

15 Best Patch Management Tools
Patch management tools are crucial for IT security and efficiency in 2025, automating software updates and security patches across various systems. Leading solutions include SolarWinds,